+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosurgery Market By Product Type, By Application, By Source: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640327
The global Biosurgery market was valued at $11,425.5 million in 2020, and is projected to reach $27,324.8 million by 2030, registering a CAGR of 9.1% from 2021 to 2030.
Biosurgery products consist of synthetic, semisynthetic or natural material that help in tissue repair and seal surgical incision. Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Biosurgery products also help facilitate tissue sealing hemostasis. Moreover, biosurgery products are used in hard tissue regeneration in ortho-biologics. Various synthetic and biologic products, such as anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for prevention of excessive blood loss or providing adhesion or wound/tissue sealing.

The growth of the global biosurgery market is majorly driven by increase in prevalence of chronic disease, trauma, rise in government and private organizations initiatives for development of the medical devices sector, surge in number of surgical procedures, and rise in demand for biosurgery products.

Furthermore, rise in number of geriatric population drives the growth of the market. This is attributed to the fact that geriatric population is highly vulnerable to chronic diseases, which boosts the need for various surgical procedure and upsurge the demand for biosurgery products. This factor is expected to notably contribute toward the growth of the global biosurgery market.

In addition, increase in sports-related injuries and surgeries, increase in sedentary lifestyle, and rise in several approvals for biosurgery, drive the growth of the global biosurgery market.

In addition, increase in R&D activities in the healthcare industry and rise in blood loss management systems are anticipated to provide lucrative opportunities for the market expansion.

However, high cost of biosurgery products and stringent government regulations hinder the market growth. On the contrary, increase in awareness among physicians and researchers about the use of biosurgery products augments the growth of the biosurgery market. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the biosurgery market.

The biosurgery market is segmented on the basis of product type, application, source, and region. Depending on the product type, the market is divided into anti-adhesive agents, hemostatic agents and surgical sealants, bone graft substitutes, and mesh (soft tissue management). On the basis of application, the market is segmented into cardiovascular and thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. On the basis of source, the market is segmented into biologics products, and synthetic products. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global biosurgery market are Aroa Biosurgery Limited, B. Braun Melsungen AG, Baxter International Inc., BD (Becton, Dickinson and Company), Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., Tissue Regenix Groups.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biosurgery market analysis from 2020 to 2030 to identify the prevailing biosurgery market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the biosurgery market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global biosurgery market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Product Type

  • Anti Adhesive Agents
  • Bone Graft Substitutes
  • Hemostatic And Surgical Sealant
  • Mesh

By Application

  • Cardiovascular And Thoracic Surgery
  • Neuro And Spine Surgery
  • Orthopedic Surgery
  • General Surgery

By Source

  • Biologics Products
  • Synthetic Products

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Australia
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • aroa biosurgery limited
  • Baxter International Inc.
  • B. BRAUN MELSUNGEN AG
  • Becton, Dickinson and Company
  • HEMOSTASIS LLC
  • INTEGRA LIFE SCIENCES HOLDINGS CORP
  • JOHNSON and JOHNSON SERVICES, INC.
  • Medtronic, Inc.
  • SANOFI S A
  • TISSUE REGENIX GROUP
Frequently Asked Questions about the Global Biosurgery Market

What is the estimated value of the Global Biosurgery Market?

The Global Biosurgery Market was estimated to be valued at $11425.5 million in 2020.

What is the growth rate of the Global Biosurgery Market?

The growth rate of the Global Biosurgery Market is 9.1%, with an estimated value of $27324.8 million by 2030.

What is the forecasted size of the Global Biosurgery Market?

The Global Biosurgery Market is estimated to be worth $27324.8 million by 2030.

Who are the key companies in the Global Biosurgery Market?

Key companies in the Global Biosurgery Market include aroa biosurgery limited, Baxter International Inc., B. BRAUN MELSUNGEN AG, Becton, Dickinson and Company, HEMOSTASIS LLC, INTEGRA LIFE SCIENCES HOLDINGS CORP, JOHNSON and JOHNSON SERVICES, INC., Medtronic, Inc. and TISSUE REGENIX GROUP.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: BIOSURGERY MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Anti Adhesive Agents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Bone Graft Substitutes
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Hemostatic And Surgical Sealant
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Mesh
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: BIOSURGERY MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Cardiovascular And Thoracic Surgery
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Neuro And Spine Surgery
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Orthopedic Surgery
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 General Surgery
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: BIOSURGERY MARKET, BY SOURCE
6.1 Overview
6.1.1 Market size and forecast
6.2 Biologics Products
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Synthetic Products
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: BIOSURGERY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by Source
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by Source
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by Source
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by Source
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by Source
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by Source
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by Source
7.3.5.3 United Kingdom
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by Source
7.3.5.4 Rest of Europe
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by Source
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by Source
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by Source
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by Source
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by Source
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by Source
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Product Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by Source
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by Source
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by Source
7.5.5.2 Turkey
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by Source
7.5.5.3 Saudi Arabia
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by Source
7.5.5.4 South Africa
7.5.5.4.1 Market size and forecast, by Product Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by Source
7.5.5.5 Rest of LAMEA
7.5.5.5.1 Market size and forecast, by Product Type
7.5.5.5.2 Market size and forecast, by Application
7.5.5.5.3 Market size and forecast, by Source
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 aroa biosurgery limited
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Baxter International Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 B. BRAUN MELSUNGEN AG
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Becton, Dickinson and Company
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 HEMOSTASIS LLC
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 INTEGRA LIFE SCIENCES HOLDINGS CORP
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 JOHNSON and JOHNSON SERVICES, INC.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Medtronic, Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 SANOFI S A
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 TISSUE REGENIX GROUP
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Biosurgery Market, by Product Type, 2020-2030, ($Million)
Table 2. Biosurgery Market Revenue, for Anti Adhesive Agents, by Region, 2020-2030, ($Million)
Table 3. Biosurgery Market Anti Adhesive Agents by Country, 2020-2030, ($Million)
Table 4. Biosurgery Market Revenue, for Bone Graft Substitutes, by Region, 2020-2030, ($Million)
Table 5. Biosurgery Market Bone Graft Substitutes by Country, 2020-2030, ($Million)
Table 6. Biosurgery Market Revenue, for Hemostatic and Surgical Sealant, by Region, 2020-2030, ($Million)
Table 7. Biosurgery Market Hemostatic and Surgical Sealant by Country, 2020-2030, ($Million)
Table 8. Biosurgery Market Revenue, for Mesh, by Region, 2020-2030, ($Million)
Table 9. Biosurgery Market Mesh by Country, 2020-2030, ($Million)
Table 10. Global Biosurgery Market, by Application, 2020-2030, ($Million)
Table 11. Biosurgery Market Revenue, for Cardiovascular and Thoracic Surgery, by Region, 2020-2030, ($Million)
Table 12. Biosurgery Market Cardiovascular and Thoracic Surgery by Country, 2020-2030, ($Million)
Table 13. Biosurgery Market Revenue, for Neuro and Spine Surgery, by Region, 2020-2030, ($Million)
Table 14. Biosurgery Market Neuro and Spine Surgery by Country, 2020-2030, ($Million)
Table 15. Biosurgery Market Revenue, for Orthopedic Surgery, by Region, 2020-2030, ($Million)
Table 16. Biosurgery Market Orthopedic Surgery by Country, 2020-2030, ($Million)
Table 17. Biosurgery Market Revenue, for General Surgery, by Region, 2020-2030, ($Million)
Table 18. Biosurgery Market General Surgery by Country, 2020-2030, ($Million)
Table 19. Global Biosurgery Market, by Source, 2020-2030, ($Million)
Table 20. Biosurgery Market Revenue, for Biologics Products, by Region, 2020-2030, ($Million)
Table 21. Biosurgery Market Biologics Products by Country, 2020-2030, ($Million)
Table 22. Biosurgery Market Revenue, for Synthetic Products, by Region, 2020-2030, ($Million)
Table 23. Biosurgery Market Synthetic Products by Country, 2020-2030, ($Million)
Table 24. Biosurgery Market, by Region, 2020-2030, ($Million)
Table 25. North America Biosurgery Market, by Product Type, 2020-2030, ($Million)
Table 26. North America Biosurgery Market, by Application, 2020-2030, ($Million)
Table 27. North America Biosurgery Market, by Source, 2020-2030, ($Million)
Table 28. North America Biosurgery Market, by Country, 2020-2030, ($Million)
Table 29. U.S. Biosurgery Market by Product Type 2020-2030, ($Million)
Table 30. U.S. Biosurgery Market by Application 2020-2030, ($Million)
Table 31. U.S. Biosurgery Market by Source 2020-2030, ($Million)
Table 32. Canada Biosurgery Market by Product Type 2020-2030, ($Million)
Table 33. Canada Biosurgery Market by Application 2020-2030, ($Million)
Table 34. Canada Biosurgery Market by Source 2020-2030, ($Million)
Table 35. Mexico Biosurgery Market by Product Type 2020-2030, ($Million)
Table 36. Mexico Biosurgery Market by Application 2020-2030, ($Million)
Table 37. Mexico Biosurgery Market by Source 2020-2030, ($Million)
Table 38. Europe Biosurgery Market, by Product Type, 2020-2030, ($Million)
Table 39. Europe Biosurgery Market, by Application, 2020-2030, ($Million)
Table 40. Europe Biosurgery Market, by Source, 2020-2030, ($Million)
Table 41. Europe Biosurgery Market, by Country, 2020-2030, ($Million)
Table 42. Germany Biosurgery Market by Product Type 2020-2030, ($Million)
Table 43. Germany Biosurgery Market by Application 2020-2030, ($Million)
Table 44. Germany Biosurgery Market by Source 2020-2030, ($Million)
Table 45. France Biosurgery Market by Product Type 2020-2030, ($Million)
Table 46. France Biosurgery Market by Application 2020-2030, ($Million)
Table 47. France Biosurgery Market by Source 2020-2030, ($Million)
Table 48. United Kingdom Biosurgery Market by Product Type 2020-2030, ($Million)
Table 49. United Kingdom Biosurgery Market by Application 2020-2030, ($Million)
Table 50. United Kingdom Biosurgery Market by Source 2020-2030, ($Million)
Table 51. Rest of Europe Biosurgery Market by Product Type 2020-2030, ($Million)
Table 52. Rest of Europe Biosurgery Market by Application 2020-2030, ($Million)
Table 53. Rest of Europe Biosurgery Market by Source 2020-2030, ($Million)
Table 54. Asia-Pacific Biosurgery Market, by Product Type, 2020-2030, ($Million)
Table 55. Asia-Pacific Biosurgery Market, by Application, 2020-2030, ($Million)
Table 56. Asia-Pacific Biosurgery Market, by Source, 2020-2030, ($Million)
Table 57. Asia-Pacific Biosurgery Market, by Country, 2020-2030, ($Million)
Table 58. China Biosurgery Market by Product Type 2020-2030, ($Million)
Table 59. China Biosurgery Market by Application 2020-2030, ($Million)
Table 60. China Biosurgery Market by Source 2020-2030, ($Million)
Table 61. Japan Biosurgery Market by Product Type 2020-2030, ($Million)
Table 62. Japan Biosurgery Market by Application 2020-2030, ($Million)
Table 63. Japan Biosurgery Market by Source 2020-2030, ($Million)
Table 64. Australia Biosurgery Market by Product Type 2020-2030, ($Million)
Table 65. Australia Biosurgery Market by Application 2020-2030, ($Million)
Table 66. Australia Biosurgery Market by Source 2020-2030, ($Million)
Table 67. India Biosurgery Market by Product Type 2020-2030, ($Million)
Table 68. India Biosurgery Market by Application 2020-2030, ($Million)
Table 69. India Biosurgery Market by Source 2020-2030, ($Million)
Table 70. Rest of Asia-Pacific Biosurgery Market by Product Type 2020-2030, ($Million)
Table 71. Rest of Asia-Pacific Biosurgery Market by Application 2020-2030, ($Million)
Table 72. Rest of Asia-Pacific Biosurgery Market by Source 2020-2030, ($Million)
Table 73. LAMEA Biosurgery Market, by Product Type, 2020-2030, ($Million)
Table 74. LAMEA Biosurgery Market, by Application, 2020-2030, ($Million)
Table 75. LAMEA Biosurgery Market, by Source, 2020-2030, ($Million)
Table 76. LAMEA Biosurgery Market, by Country, 2020-2030, ($Million)
Table 77. Brazil Biosurgery Market by Product Type 2020-2030, ($Million)
Table 78. Brazil Biosurgery Market by Application 2020-2030, ($Million)
Table 79. Brazil Biosurgery Market by Source 2020-2030, ($Million)
Table 80. Turkey Biosurgery Market by Product Type 2020-2030, ($Million)
Table 81. Turkey Biosurgery Market by Application 2020-2030, ($Million)
Table 82. Turkey Biosurgery Market by Source 2020-2030, ($Million)
Table 83. Saudi Arabia Biosurgery Market by Product Type 2020-2030, ($Million)
Table 84. Saudi Arabia Biosurgery Market by Application 2020-2030, ($Million)
Table 85. Saudi Arabia Biosurgery Market by Source 2020-2030, ($Million)
Table 86. South Africa Biosurgery Market by Product Type 2020-2030, ($Million)
Table 87. South Africa Biosurgery Market by Application 2020-2030, ($Million)
Table 88. South Africa Biosurgery Market by Source 2020-2030, ($Million)
Table 89. Rest of LAMEA Biosurgery Market by Product Type 2020-2030, ($Million)
Table 90. Rest of LAMEA Biosurgery Market by Application 2020-2030, ($Million)
Table 91. Rest of LAMEA Biosurgery Market by Source 2020-2030, ($Million)
Table 92. Aroa Biosurgery Limited: Company Snapshot
Table 93. Aroa Biosurgery Limited: Operating Segments
Table 94. Aroa Biosurgery Limited: Product Portfolio
Table 95. Aroa Biosurgery Limited: Net Sales
Table 96. Aroa Biosurgery Limited: Key Stratergies
Table 97. Baxter International Inc.: Company Snapshot
Table 98. Baxter International Inc.: Operating Segments
Table 99. Baxter International Inc.: Product Portfolio
Table 100. Baxter International Inc.: Net Sales
Table 101. Baxter International Inc.: Key Stratergies
Table 102. B. Braun Melsungen Ag: Company Snapshot
Table 103. B. Braun Melsungen Ag: Operating Segments
Table 104. B. Braun Melsungen Ag: Product Portfolio
Table 105. B. Braun Melsungen Ag: Net Sales
Table 106. B. Braun Melsungen Ag: Key Stratergies
Table 107. Becton, Dickinson and Company: Company Snapshot
Table 108. Becton, Dickinson and Company: Operating Segments
Table 109. Becton, Dickinson and Company: Product Portfolio
Table 110. Becton, Dickinson and Company: Net Sales
Table 111. Becton, Dickinson and Company: Key Stratergies
Table 112. Hemostasis LLC: Company Snapshot
Table 113. Hemostasis LLC: Operating Segments
Table 114. Hemostasis LLC: Product Portfolio
Table 115. Hemostasis LLC: Net Sales
Table 116. Hemostasis LLC: Key Stratergies
Table 117. Integra Life Sciences Holdings Corp: Company Snapshot
Table 118. Integra Life Sciences Holdings Corp: Operating Segments
Table 119. Integra Life Sciences Holdings Corp: Product Portfolio
Table 120. Integra Life Sciences Holdings Corp: Net Sales
Table 121. Integra Life Sciences Holdings Corp: Key Stratergies
Table 122. Johnson and Johnson Services, Inc.: Company Snapshot
Table 123. Johnson and Johnson Services, Inc.: Operating Segments
Table 124. Johnson and Johnson Services, Inc.: Product Portfolio
Table 125. Johnson and Johnson Services, Inc.: Net Sales
Table 126. Johnson and Johnson Services, Inc.: Key Stratergies
Table 127. Medtronic, Inc.: Company Snapshot
Table 128. Medtronic, Inc.: Operating Segments
Table 129. Medtronic, Inc.: Product Portfolio
Table 130. Medtronic, Inc.: Net Sales
Table 131. Medtronic, Inc.: Key Stratergies
Table 132. Sanofi S A: Company Snapshot
Table 133. Sanofi S A: Operating Segments
Table 134. Sanofi S A: Product Portfolio
Table 135. Sanofi S A: Net Sales
Table 136. Sanofi S A: Key Stratergies
Table 137. Tissue Regenix Group: Company Snapshot
Table 138. Tissue Regenix Group: Operating Segments
Table 139. Tissue Regenix Group: Product Portfolio
Table 140. Tissue Regenix Group: Net Sales
Table 141. Tissue Regenix Group: Key Stratergies
LIST OF FIGURES
Figure 1. Biosurgery Market Segmentation
Figure 2. Biosurgery Market, 2020-2030
Figure 3. Biosurgery Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Biosurgery Market:Drivers, Restraints and Opportunities
Figure 11. Biosurgery Market, by Product Type, 2020 (%)
Figure 12. Comparative Share Analysis of Anti Adhesive Agents Biosurgery Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Bone Graft Substitutes Biosurgery Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Hemostatic and Surgical Sealant Biosurgery Market, 2020-2030 (%)
Figure 15. Comparative Share Analysis of Mesh Biosurgery Market, 2020-2030 (%)
Figure 16. Biosurgery Market, by Application, 2020 (%)
Figure 17. Comparative Share Analysis of Cardiovascular and Thoracic Surgery Biosurgery Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Neuro and Spine Surgery Biosurgery Market, 2020-2030 (%)
Figure 19. Comparative Share Analysis of Orthopedic Surgery Biosurgery Market, 2020-2030 (%)
Figure 20. Comparative Share Analysis of General Surgery Biosurgery Market, 2020-2030 (%)
Figure 21. Biosurgery Market, by Source, 2020 (%)
Figure 22. Comparative Share Analysis of Biologics Products Biosurgery Market, 2020-2030 (%)
Figure 23. Comparative Share Analysis of Synthetic Products Biosurgery Market, 2020-2030 (%)
Figure 24. Biosurgery Market by Region, 2020
Figure 25. U.S. Biosurgery Market, 2020-2030 ($Million)
Figure 26. Canada Biosurgery Market, 2020-2030 ($Million)
Figure 27. Mexico Biosurgery Market, 2020-2030 ($Million)
Figure 28. Germany Biosurgery Market, 2020-2030 ($Million)
Figure 29. France Biosurgery Market, 2020-2030 ($Million)
Figure 30. United Kingdom Biosurgery Market, 2020-2030 ($Million)
Figure 31. Rest of Europe Biosurgery Market, 2020-2030 ($Million)
Figure 32. China Biosurgery Market, 2020-2030 ($Million)
Figure 33. Japan Biosurgery Market, 2020-2030 ($Million)
Figure 34. Australia Biosurgery Market, 2020-2030 ($Million)
Figure 35. India Biosurgery Market, 2020-2030 ($Million)
Figure 36. Rest of Asia-Pacific Biosurgery Market, 2020-2030 ($Million)
Figure 37. Brazil Biosurgery Market, 2020-2030 ($Million)
Figure 38. Turkey Biosurgery Market, 2020-2030 ($Million)
Figure 39. Saudi Arabia Biosurgery Market, 2020-2030 ($Million)
Figure 40. South Africa Biosurgery Market, 2020-2030 ($Million)
Figure 41. Rest of LAMEA Biosurgery Market, 2020-2030 ($Million)
Figure 42. Top Winning Strategies, by Year
Figure 43. Top Winning Strategies, by Development
Figure 44. Top Winning Strategies, by Company
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap of Top 10 Key Players
Figure 48. Aroa Biosurgery Limited.: Net Sales, ($Million)
Figure 49. Baxter International Inc. Net Sales, ($Million)
Figure 50. B. Braun Melsungen AG.: Net Sales, ($Million)
Figure 51. Becton, Dickinson and Company.: Net Sales, ($Million)
Figure 52. Hemostasis LLC.: Net Sales, ($Million)
Figure 53. Integra Life Sciences Holdings Corp.: Net Sales, ($Million)
Figure 54. Johnson and Johnson Services, Inc. Net Sales, ($Million)
Figure 55. Medtronic, Inc. Net Sales, ($Million)
Figure 56. Sanofi S A.: Net Sales, ($Million)
Figure 57. Tissue Regenix Group.: Net Sales, ($Million)

Executive Summary

Biosurgery is defined as a surgical technique, which is used to reduce intra- and post-operative complications by facilitating hemostasis and tissue sealing. It offers application in hard tissue regeneration in orthobiologics. Bio-surgery products contain primarily semi-synthetic, synthetic, or natural materials that help is sealing surgical incisions. They also control loss of blood for various surgical conditions, such as cardiovascular surgery, gynecology surgery, and orthopedic surgery.
Factors that drive growth of the global biosurgery market size include, rise in demand for surgical procedure, advancements in the medical device industry, and surge in demand for biosurgery products. In addition, rise in prevalence of chronic diseases contributes toward the growth of the global biosurgery market. Market players focus on manufacturing of different biosurgery products to offer better outcome after surgical procedures. Moreover, increase in prevalence of geriatric population and surge in need for blood loss management system accelerate the biosurgery market growth.
Moreover, rise in disposable income and development of R&D activities for manufacturing advanced biosurgery products are anticipated to drive the growth of the biosurgery market share. Rise in sedentary lifestyle and increase in number of sports-related injuries and surgeries, surge the need for biosurgery products, and surge the demand for biosurgery industry. These are the key factors that boost growth of the biosurgery market size.
The biosurgery market is segmented on the basis of product type, application, source, and region. Depending on product, the market is divided into anti-adhesive agents, hemostatic agents, surgical sealants, bone graft substitutes, and mesh. The bone graft substitutes segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to surge in demand for bone graft substituent product and increase in number of sports injuries and surgeries. Depending on application, the market is divided into thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. The neuro and spine surgery segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in prevalence of neurological disorder.

Depending on source, the market is divided into biologics products, and synthetic products. The biologics products segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in demand for natural products and rise in technological development in pharmaceutical sector.

The COVID-19 outbreak negatively impacted growth of the global biosurgery market. The COVID-19 pandemic stressed healthcare systems across the globe. The soft tissue orthopaedic and urogynecology procedure is profoundly affected by the COVID-19 pandemic. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to the COVID-19 outbreak resulted in decline in number of patient visits for other diseases, such as cancer and diabetes, during the pandemic. For instance, in 2021, Tissue Regenix Group, a medical technology company, reported that approximately 22% of biosurgery revenue decreased due to cancellation of elective surgical procedures.
According to Onkar Sumant, Manager, Healthcare, 'Alarming rise in prevalence of chronic diseases, advancements in the medical device sector, rise in demand for biosurgery products, and increase in number of sports-related surgery are expected to notably contribute toward the growth of the global biosurgery market analysis during the forecast period.'

KEY FINDINGS OF THE STUDY

  • On the basis of product type, the bone graft substitutes segment was the highest contributor to the market in 2020, and is expected to continue this trend during the biosurgery market forecast period.
  • On the basis of application, the neuro and spine surgery segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
  • On the basis of source, the biologics product segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
  • Region-wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
North America garnered a major share of the biosurgery market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of chronic disease, increase in number of surgery, and presence of key players for manufacturing biosurgery products, and development in R&D activities in healthcare sector. However, Asia-Pacific is expected to register highest CAGR of 10.2% from 2021 to 2030 owing to increase in number of geriatric population, rise in number of sport related surgery and injury, and increase in demand for biosurgery products

Companies Mentioned

  • aroa biosurgery limited
  • Baxter International Inc.
  • B. BRAUN MELSUNGEN AG
  • Becton, Dickinson and Company
  • HEMOSTASIS LLC
  • INTEGRA LIFE SCIENCES HOLDINGS CORP
  • JOHNSON and JOHNSON SERVICES, INC.
  • Medtronic, Inc.
  • SANOFI S A
  • TISSUE REGENIX GROUP

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...